Skip to main content

Table 3 Changes of TRAb and TPOAb at different time after 131I treatment

From: The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease

 

GD patients with decreased antibodies

GD patients with increased antibodies

GD patients with unchanged antibodies

 

TRAb***

TPOAb###

TRAb

TPOAb

TRAb

TPOAb

1-6 m

18% (4/22)

0 (0/22)

73% (16/22)

27% (6/22)

9% (2/22)

73% (16/22)

7-12 m

36% (10/28)

7% (2/28)

53% (15/28)

29% (8/28)

11% (3/28)

64% (18/28)

13-60 m

79% (83/105)

38% (40/105)

19% (20/105)

15% (16/105)

2% (2/105)

47% (49/105)

>60 m

88% (42/48)

65% (31/48)

2% (1/48)

12% (6/48)

10% (5/48)

23% (11/48)

  1. TRAb or TPOAb increased: TRAb of 131I therapy after/before ≥1.1
  2. TRAb or TPOAb decreased: TRAb of 131I therapy before/after ≥1.1
  3. ***p <0.001 represents changes of TRAb comes from Trend Test
  4. ###p <0.001 represents changes of TPOAb comes from Trend Test